Shanghai, February 6, 2025 – KDN Biotech Co., Ltd. (hereafter referred to as “KDN Biotech”) and Univar Solutions China Ltd. (hereafter referred to as “Univar Solutions”) officially signed a strategic distribution agreement in the probiotic pet industry today. This partnership marks an important step in deepening their collaboration in the field of pet health, with the goal of advancing the application and development of probiotics in the pet industry.
KDN Biotech, a subsidiary of the publicly listed company Blue Bio, has been committed to the research and application of biotechnology, with a particular focus on probiotics. The company boasts advanced technological capabilities and a comprehensive product line in this field. Blue Bio’s extensive experience in biotechnology provides KDN Biotech with strong technical support, securing a leading position for the company in the enzyme and probiotic markets.
Univar Solutions, a century-old enterprise renowned for its focus on chemical product distribution and services, brings its vast sales network and rich market experience to the table. Through this collaboration, Univar Solutions will become a key distribution partner for KDN Biotech’s probiotic products in the pet industry. Together, the two companies will work to explore and expand the probiotic pet market, promoting the
widespread application and adoption of pet health products.
This partnership not only represents a significant strategic move for KDN Biotech and Univar Solutions in the pet health sector but also injects new vitality into the entire pet industry. As the pet economy continues to grow, the demand for probiotics, a crucial component of pet health, is expected to expand further. The strong alliance between KDN Biotech and Univar Solutions will undoubtedly bring more innovation and opportunities to the pet health industry.
Looking ahead, both companies are committed to deepening their collaboration and exploring additional applications for probiotics in the pet health field, ultimately driving the sustainable development of the pet health industry.
Shanghai, February 6, 2025 – KDN Biotech Co., Ltd. (hereafter referred to as “KDN Biotech”) and Univar Solutions China Ltd. (hereafter referred to as “Univar Solutions”) officially signed a strategic distribution agreement in the probiotic pet industry today. This partnership marks an important step in deepening their collaboration in the field of pet health, with the goal of advancing the application and development of probiotics in the pet industry.
KDN Biotech, a subsidiary of the publicly listed company Blue Bio, has been committed to the research and application of biotechnology, with a particular focus on probiotics. The company boasts advanced technological capabilities and a comprehensive product line in this field. Blue Bio’s extensive experience in biotechnology provides KDN Biotech with strong technical support, securing a leading position for the company in the enzyme and probiotic markets.
Univar Solutions, a century-old enterprise renowned for its focus on chemical product distribution and services, brings its vast sales network and rich market experience to the table. Through this collaboration, Univar Solutions will become a key distribution partner for KDN Biotech’s probiotic products in the pet industry. Together, the two companies will work to explore and expand the probiotic pet market, promoting the
widespread application and adoption of pet health products.
This partnership not only represents a significant strategic move for KDN Biotech and Univar Solutions in the pet health sector but also injects new vitality into the entire pet industry. As the pet economy continues to grow, the demand for probiotics, a crucial component of pet health, is expected to expand further. The strong alliance between KDN Biotech and Univar Solutions will undoubtedly bring more innovation and opportunities to the pet health industry.
Looking ahead, both companies are committed to deepening their collaboration and exploring additional applications for probiotics in the pet health field, ultimately driving the sustainable development of the pet health industry.
